Compare Chemcrux Enterp. with Similar Stocks
Dashboard
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 3.09 times
Poor long term growth as Operating profit has grown by an annual rate -23.61% of over the last 5 years
With a growth in Net Profit of 780.95%, the company declared Very Positive results in Mar 26
With ROCE of 6.9, it has a Attractive valuation with a 1.7 Enterprise value to Capital Employed
Majority shareholders : Promoters
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Specialty Chemicals
INR 137 Cr (Micro Cap)
38.00
44
1.10%
0.21
4.85%
1.75
Total Returns (Price + Dividend) 
Latest dividend: 1 per share ex-dividend date: Sep-17-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Chemcrux Enterprises Ltd is Rated Hold
Chemcrux Enterprises Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 14 May 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 30 July 2026, providing investors with the latest insights into its performance and outlook.
Read full news articleWhen is the next results date for Chemcrux Enterprises Ltd?
The next results date for Chemcrux Enterprises Ltd is scheduled for August 4, 2026....
Read full news article
Chemcrux Enterprises Ltd is Rated Hold
Chemcrux Enterprises Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 14 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 July 2026, providing investors with an up-to-date perspective on its performance and outlook.
Read full news article Announcements 
Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended 30Th June 2026 For F.Y. 2026-27 And Other Related Matters Thereto And To Consider Any Other Business /Agenda.
28-Jul-2026 | Source : BSEChemcrux Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 inter alia to consider and approve 1. Unaudited Financial Results for the quarter ended 30th June 2026 for F.Y. 2026-27 and other related matters thereto. 2. To consider any other business /agenda.
Announcement under Regulation 30 (LODR)-Updates on Acquisition
17-Jul-2026 | Source : BSEUpdates on Acquisition - Incorporation of Chemcrux Foundation (Section 8 Company)
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
09-Jul-2026 | Source : BSECertificate u/r 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 30th June 2026
Corporate Actions 
04 Aug 2026
Chemcrux Enterprises Ltd has declared 10% dividend, ex-date: 17 Sep 25
No Splits history available
Chemcrux Enterprises Ltd has announced 2:1 bonus issue, ex-date: 06 Sep 21
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Sanjay Marathe (36.46%)
Prasenjit Kumar Paul (1.48%)
25.85%
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
YoY Growth in quarter ended Mar 2026 is 54.45% vs -15.21% in Mar 2025
YoY Growth in quarter ended Mar 2026 is 780.95% vs -90.50% in Mar 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -1.75% vs -8.55% in Sep 2024
Growth in half year ended Sep 2025 is -87.03% vs -33.05% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 3.83% vs -9.43% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -49.06% vs -40.45% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 15.20% vs -10.78% in Mar 2025
YoY Growth in year ended Mar 2026 is -4.60% vs -53.67% in Mar 2025






